Acute Myeloid Leukemia Market worth $3.21 Billion by 2028 | Top Keyplayers Are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc.

Overview and Scope

Acute myeloid leukemia (AML) is a type of blood cancer that occurs due to abnormal white blood cell in bone marrow. Myeloblasts, also known as leukemic blasts, or excessive production of immature white blood cells, are the hallmark of AML. The bone marrow is crowded with these cells, which stops it from producing healthy blood cells.

 

Sizing and Forecast

The acute myeloid leukemia market size has grown strongly in recent years. It will grow from $2.21 billion in 2023 to $2.39 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%.  The growth in the historic period can be attributed to growth aging population, environmental factors, genetic predisposition, limited treatment options, medical advancements.

 

The acute myeloid leukemia market size is expected to see strong growth in the next few years. It will grow to $3.21 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%.  The growth in the forecast period can be attributed to growing advancements in targeted therapies, immunotherapies development, precision medicine approaches, increased awareness and early detection, collaborative research initiatives. Major trends in the forecast period include emphasis on minimal residual disease monitoring, integration of artificial intelligence (ai) in treatment decision support, focus on supportive care and quality of life interventions, collaborative research initiatives and clinical trials, patient advocacy and empowerment programs.

 

Order your report now for swift delivery, visit the link:

https://www.thebusinessresearchcompany.com/report/acute-myeloid-leukemia-global-market-report

 

Segmentation & Regional Insights

The acute myeloid leukemia market covered in this report is segmented –

1) By Treatment Type: Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy

2) By Chemotherapy: Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy

3) By Regimen: DC Regimen, AVD Regimen, VCD Regimen

4) By End-User: Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics

 

 

North America was the largest region in the acute myeloid leukemia market in 2023. The regions covered in the acute myeloid leukemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6100&type=smp

 

Major Driver Impacting Market Growth

The increase in the older population base and growing unmet healthcare needs is expected to propel the growth of the acute myeloid leukemia market over the coming years. The geriatric population and growing unmet healthcare are defined as the elderly population, people aged 65 and over suffering from health issues like acute myeloid leukemia. For instance, according to the American Cancer Society USA (ACS), a nationwide voluntary health organization, in 2022, AML was commonly found in elderly people with an average age at diagnosis being 68, and survival of elderly AML patients remained remarkably low. It affected approximately 60,650 people in 2022 and caused 24000 deaths. Therefore, the geriatric population base and growing unmet healthcare needs drive the gelatin market.

 

Key Industry Players

Major companies operating in the acute myeloid leukemia market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Sanofi-Aventis (Genzyme Corporation), Bristol Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceuticals, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical, Celgene Corporation, Astellas Pharma, Servier Pharmaceuticals, CSPC Pharmaceutical Group, Genmab AS, Zhejiang Medicine Co. Ltd., Syndax Pharmaceuticals Inc., Astex Pharmaceuticals Inc., MEI Pharma Inc., SELLAS Life Sciences Group, Ambit Biosciences Corporation, Agios Pharmaceuticals Inc., Neomed Management AS, Oncolyze Inc., TC BioPharm, VERASTEM INC., Mirati Therapeutics Inc., Sunshine Lake Pharma, Sunesis Pharmaceuticals Inc.

 

The acute myeloid leukemia market report table of contents includes:

1. Executive Summary
2. Acute Myeloid Leukemia Market Characteristics
3. Acute Myeloid Leukemia Market Trends And Strategies
4. Acute Myeloid Leukemia Market – Macro Economic Scenario
5. Global Acute Myeloid Leukemia Market Size and Growth
6. Acute Myeloid Leukemia Market Segmentation
7. Acute Myeloid Leukemia Market Regional And Country Analysis

……………..

34. Key Mergers And Acquisitions In The Acute Myeloid Leukemia Market
35. Acute Myeloid Leukemia Market Future Outlook and Potential Analysis
36. Appendix

 

List Of Tables:

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Acute Myeloid Leukemia Market, Segmentation By Regimen, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

…………..

Table 75: Pfizer Inc. Financial Performance

Table 76: F. Hoffmann-La Roche AG Financial Performance

Table 77: AbbVie Inc. Financial Performance

Table 78: Novartis AG Financial Performance

Table 79: Sanofi-Aventis (Genzyme Corporation) Financial Performance

 

Explore the trending research reports from TBRC:

https://goodprnews.com/insurtech-market-growth/

https://topprnews.com/global-low-earth-orbit-leo-satellites-market-share/

 

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model